title: Enhanced clinical utility of de novo cyclosporine C2 monitoring after lung transplantation.
authors.affiliation: Lung Transplant Unit, St. Vincent's Hospital, Sydney, NSW, Australia.
authors.forename: Judith M
authors.initials: JM
authors.lastname: Morton
authors.forename: Christina L
authors.initials: CL
authors.lastname: Aboyoun
authors.forename: Monique A
authors.initials: MA
authors.lastname: Malouf
authors.forename: Marshall L
authors.initials: ML
authors.lastname: Plit
authors.forename: Allan R
authors.initials: AR
authors.lastname: Glanville
mesh_terms: D000328:Adult; D019540:Area Under Curve; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000032:analysis*; D016903:Drug Monitoring; D005260:Female; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000032:analysis*; D007674:Kidney Diseases / Q000139:chemically induced; D016040:Lung Transplantation; D008297:Male; D008875:Middle Aged
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine